| | | Index Performance | | Index | Sensex | Nifty | | Open | 13,734.01 | 3,942.75 | | High | 13,911.59 | 3,986.75 | | Low | 13,734.01 | 3,937.70 | | Today's Cls | 13,859.69 | 3,974.25 | | Prev Cls | 13,708.34 | 3,940.50 | | Change | 151.35 | 33.75 | | % Change | 1.10 | 0.86 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | IndusInd Bank | 47.20 | 10.15 | | Punjab Tractors | 251.65 | 8.07 | | EIH | 110.20 | 6.37 | | BEL | 1,344.45 | 5.73 | | Ipca Lab | 554.85 | 5.61 | | Losers | | Zee Telefilms | 283.35 | -2.60 | | Ingersoll Rand | 360.00 | -2.51 | | Moser Baer | 304.70 | -2.39 | | Micro Inks | 327.20 | -2.33 | | Nestle | 1,097.05 | -2.30 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,355 | 736 | | Declines | 1,264 | 559 | | Unchanged | 87 | 31 | | Volume(Nos) | 20.34cr | 25.46cr | | | | | | Market Commentary | | | Market on a roll, 151 points up | | On the back of strong buying, the Sensex has rallied to touch a new intra-day high of 13912. | | The market continued with its awesome display for the fourth consecutive session and scaled new peaks on the back of an all-round buying support. | | | Resuming on a firm note at 13734, 26 points above its previous close of 13708, the Sensex rallied sharply and zoomed above the 13900 mark to touch a new intra-day high of 13912 on a strong upmove in most of the index heavyweights and the other side counters. However, profit taking, particularly in select counters, towards the close saw the Sensex pare its gains considerably and close at 13860, up 151 points. The Nifty also edged higher and advanced 34 points to close at 3974.
The breadth of the market was slightly positive. Of the 2,705 stocks traded on the BSE, 1,355 stocks advanced, 1,264 stocks declined and 87 ended unchanged. Among the sectoral indices, the BSE Bankex , Auto, CD, HC, IT and the Tech indices rose by over 1% each, while the BSE CG, FMCG, Metal, Oil & Gas and PSU indices ended with steady gains. | | | Movers & Shakers | - Wockhardt gained marginally on reports that the US subsidiary of the company has launched Ondansetron injection in the USA.
- Dr Reddy’s Lab moved up on receiving the approval for its abbreviated new drug application for Ondansetron Hydrochloride tablets.
- Mazda tumbled despite receiving an order of Rs2.37 crore from PI Industries.
- IndusInd Bank rallied sharply on receiving fresh authorisation from RBI for opening 19 more branches.
- Nagarjuna Construction Company gained on securing three new orders aggregating Rs370 crore.
- Great Offshore closed in the green on reports that the company has taken delivery of a newly built anchor handling tug supply vessel.
| | | |
Among the movers of the index, Satyam Computers soared 3.24% at Rs492, Tata Motors rose 2.54% at Rs907, HDFC Bank scaled up 2.53% at Rs1,057, ICICI Bank added 2.51% at Rs894, Gujarat Ambuja Cements moved up by 1.79% at Rs142, Wipro gained 1.66% at Rs607 and Reliance Communication was up 1.65% at Rs475. Infosys, Cipla and HDFC gained over 1% each. However, ONGC came under profit booking and lost 1.70% at Rs873, while Hero Honda declined 0.63% at Rs744. HLL, Reliance Energy, L&T and Maruti Udyog ended with marginal losses.
Mahindra & Mahindra at Rs899, Garware Offshore at Rs300.25, NCL Industries at Rs64.40, Modern India at Rs164.60, Simplex Trading at Rs93.95, Setco Auto at Rs173.25, Texmaco at Rs1,170.10 and Millars India at Rs143.65 touched new intra-day highs on the BSE.
Over 21.15 lakh EIH shares changed hands on the BSE followed by Reliance Communication (15.74 lakh shares), Sterling Biotech (15.55 lakh shares), Ashok Leyland (14.78 lakh shares) and IndusInd Bank (14.50 lakh shares).
| | | | | | | | European Indices at 16:03 IST on 27-12-2006 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 6240.20 | 50.20 | 0.81 | | CAC 40 Index | 5518.19 | 64.25 | 1.18 | | DAX Index | 6581.90 | 78.77 | 1.21 | | | | | | | | | | | Asian Indices at close on 27-12-2006 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 17223.15 | 53.96 | 0.31 | | Hang Seng Index | 19725.73 | 405.21 | 2.10 | | Kospi Index | 1425.10 | -8.82 | -0.62 | | Straits Times Index | 2961.25 | 18.72 | 0.64 | | Jakarta Composite Index | 1803.26 | 19.29 | 1.08 | | | | | | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com
| |
No comments:
Post a Comment